Listed by the USPTO as CERIONI, DANIEL LEE
Tech Center 3700 • Art Units: 3736 3791 3792
This examiner grants 64% of resolved cases
CERIONI, DANIEL LEE has resolved 793 cases in tech center 3700 and art unit 3736. The allowance rate is 64.4%, with an interview lift of 27.6%. The median time to allowance is 1291 days. The substantial case volume makes the allowance and interview figures useful indicators of recurring prosecution conditions rather than isolated results.
The leading companies are Abbott Laboratories, ViOptix Inc., and GE Precision Healthcare LLC. The leading firms are AMPACC Law Group PLLC, BUCHANAN INGERSOLL & ROONEY PC, and Dentons Durham Jones Pinegar. Interviews appear to be a meaningful part of the prosecution process, but the median timing shows that obtaining allowance may require extended case management. Practitioners should prepare interview objectives that connect directly to claim amendments and evidence in the record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19231341 | MOTION ACTIVITY BASED ESCALATION OF HEART RATE SENSOR | Non-Final OA | Apple Inc. |
| 18973934 | BIOPSY CAP ASSEMBLIES | Non-Final OA | Boston Scientific Medical Device Limited |
| 18782190 | OXYGEN MEASUREMENT DEVICE AND OXYGEN MEASUREMENT SYSTEM | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18173753 | SENSING SYSTEMS AND METHODS FOR PROVIDING DECISION SUPPORT AROUND KIDNEY HEALTH AND/OR DIABETES | Final Rejection | Dexcom, Inc. |
| 18938592 | NEONATAL POD WITH CHARGER | Final Rejection | GE Precision Healthcare LLC |
| 18647171 | METHOD FOR ESTIMATING A BODY SURFACE AREA OF A SUBJECT AND MEDICAL IMAGING DEVICE | Non-Final OA | Siemens Healthineers AG |
| 18710896 | Implant Arrangement Enabling Virtual Programming of an Implant | Final Rejection | BIOTRONIK SE & Co. KG |
| 18789387 | BACKGROUND INTERFERENCE MITIGATION FOR HIGH SENSITIVITY CREATININE SENSING | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18321265 | MEDICAL DEVICE INCLUDING A SOLDERABLE LINEAR ELASTIC NICKEL-TITANIUM DISTAL END SECTION AND METHODS OF PREPARATION THEREFOR | Non-Final OA | Abbott Cardiovascular Systems, Inc. |
| 17723365 | CATHETER WITH ATRAUMATIC TIP | Final Rejection | St. Jude Medical, Atrial Fibrillation Division Inc |
| 17416431 | METHOD FOR EVALUATING USAGE DATA | Final Rejection | Otto Bock Healthcare Products GmbH |
| 19040904 | METHOD AND SYSTEM FOR SIGNAL ELEVATION BASED MUSCLE ACTIVITY DETECTION | Non-Final OA | Tata Consultancy Services Limited |
| 19227121 | BRAIN WAVE PATTERN CHARACTERIZATION | Non-Final OA | The Texas A&M University System |
| 18611917 | SENSOR WITH VARYING STIFFNESS | Non-Final OA | Roche Diabetes Care, Inc. |
| 15920966 | Catheter Assembly With Offset Device For Tissue Sampling | Non-Final OA | GYRUS ACMI, INC D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA |
| 17151081 | FLEXIBLE SURGICAL INSTRUMENTS FOR PERCUTANEOUS AND NEUROSURGICAL APPLICATIONS | Non-Final OA | The Chinese University of Hong Kong |
| 18669801 | IMPLANTABLE CHEMICAL SENSOR PACKAGES WITH CALIBRATION FEATURES | Final Rejection | Cardiac Pacemakers, Inc. |
| 18135837 | Blood Saving Blood Collection Device | Non-Final OA | Becton, Dickinson and Company |
| 18117765 | Blood Access Device with Integrated Blood Diagnostics | Final Rejection | Becton, Dickinson and Company |
| 17995865 | APPARATUS AND METHODS FOR ACQUISITION OF MICROBIOPSY TISSUE SAMPLES USING A LASER | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18965670 | SENSING PLATFORMS WITH NEEDLES AND METHODS OF FABRICATION AND USE | Non-Final OA | Purdue Research Foundation |
| 17970095 | POINT-OF-CARE ASSESSMENT SYSTEM | Final Rejection | The Curators of the University of Missouri |
| 18833605 | EVALUATION METHOD, EVALUATION APPARATUS, AND RECORDING MEDIUM | Final Rejection | SHISEIDO COMPANY, LTD. |
| 18979814 | Methods And Kits For Assessing Central Nervous System Integrity | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.4% of resolved applications examined by Daniel Lee Cerioni were allowed (793 resolved cases), compared with 56.2% across Art Unit 3736 over the last five years.
This examiner's interview lift is +27.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Daniel Lee Cerioni took 1,291 days on average from filing to allowance.
Daniel Lee Cerioni examines applications in Art Unit 3736 in Tech Center 3700 (Medical Devices & Mechanical Engineering).